Kodiak Sciences reports Phase 3 wins for Zenkuda and tabirafusp-ted, outlines BLA timelinesNov 12Quarterly update4D Molecular TherapeuticsKodiak Sciences Inc
Cullinan reports Q3 2026 results, flags December CLN-978 data and zipalertinib NDA progressNov 10Quarterly updateBlossomHill TherapeuticsCLN-978
Cullinan and Taiho start FDA review of zipalertinib combo for first-line lung cancerOct 1Clinical readoutCLN-049CLN-978Updated